Teva Pharmaceutical Industries Earnings
NYSE: TEVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$0.70
Teva Pharmaceutical Industries earnings summary
Teva Pharmaceutical Industries is scheduled to report Sep/2026 earnings on Nov 3, 2026 before the market opens, with analysts expecting EPS of $0.70. In its most recent report on Jul 29, 2026 (Q2 2026), TEVA posted EPS of $-0.49. Revenue for the quarter was $4.14 billion.
Quarterly EPS is down 304.2% from the same quarter a year earlier. Across the last 16 reports, TEVA shares moved an average of 3.1% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
TEVA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 29, 2026 | — | $-0.49 | — | +1.0% |
| Apr 29, 2026 | — | $0.31 | — | +2.2% |
| Feb 3, 2026 | — | $0.42 | — | -2.0% |
| Nov 5, 2025 | — | $0.37 | — | +6.0% |
| Jul 30, 2025 | — | $0.24 | — | +6.4% |
| May 7, 2025 | — | $0.18 | — | +0.1% |
| Feb 5, 2025 | — | $-0.19 | — | -3.4% |
| Nov 6, 2024 | — | $-0.39 | — | -4.0% |
| Jul 31, 2024 | — | $-0.75 | — | +2.6% |
| May 8, 2024 | — | $-0.12 | — | +0.2% |
| Feb 12, 2024 | — | $0.42 | — | -1.0% |
| Nov 9, 2023 | — | $0.06 | — | +4.3% |
| Aug 2, 2023 | — | $-0.78 | — | +0.2% |
| May 10, 2023 | — | $-0.20 | — | -1.5% |
| Feb 10, 2023 | — | $-1.17 | — | -1.9% |
| Nov 3, 2022 | — | $0.05 | — | +11.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.